CY1110520T1 - Παραγωγα 5-υποκατεστημενης κινολινης και ισοκινολινης· μεθοδος για την παραγωγη τους και η χρηση τους ως αντιφλεγμονωδη - Google Patents
Παραγωγα 5-υποκατεστημενης κινολινης και ισοκινολινης· μεθοδος για την παραγωγη τους και η χρηση τους ως αντιφλεγμονωδηInfo
- Publication number
- CY1110520T1 CY1110520T1 CY20091101074T CY091101074T CY1110520T1 CY 1110520 T1 CY1110520 T1 CY 1110520T1 CY 20091101074 T CY20091101074 T CY 20091101074T CY 091101074 T CY091101074 T CY 091101074T CY 1110520 T1 CY1110520 T1 CY 1110520T1
- Authority
- CY
- Cyprus
- Prior art keywords
- isokinoline
- inflammatory
- derivatives
- production
- substituted quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η εφεύρεση αναφέρεται σε ενώσεις τω γενικών τύπων (ΙΙa) ή (IIb) και στη χρήση αυτών ως φάρμακα.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004055633A DE102004055633A1 (de) | 2004-11-12 | 2004-11-12 | 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| DE102005020331A DE102005020331A1 (de) | 2005-04-26 | 2005-04-26 | 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| EP05808294A EP1844039B1 (de) | 2004-11-12 | 2005-11-11 | 5-substituierte chinolin- und isochinolin-derivate; ein verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110520T1 true CY1110520T1 (el) | 2015-04-29 |
Family
ID=35613753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101074T CY1110520T1 (el) | 2004-11-12 | 2009-10-15 | Παραγωγα 5-υποκατεστημενης κινολινης και ισοκινολινης· μεθοδος για την παραγωγη τους και η χρηση τους ως αντιφλεγμονωδη |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1844039B1 (el) |
| JP (1) | JP4460608B2 (el) |
| KR (1) | KR101168462B1 (el) |
| CN (1) | CN101124220B (el) |
| AR (1) | AR051767A1 (el) |
| AU (1) | AU2005303926B2 (el) |
| BR (1) | BRPI0517797A (el) |
| CA (1) | CA2586689C (el) |
| CY (1) | CY1110520T1 (el) |
| DE (2) | DE102004055633A1 (el) |
| DK (1) | DK1844039T3 (el) |
| EA (1) | EA013076B1 (el) |
| ES (1) | ES2329599T3 (el) |
| GT (1) | GT200500330A (el) |
| HK (1) | HK1112243A1 (el) |
| HR (1) | HRP20090509T1 (el) |
| IL (1) | IL182933A (el) |
| ME (2) | MEP13608A (el) |
| MX (1) | MX2007005736A (el) |
| MY (1) | MY141780A (el) |
| NO (1) | NO332405B1 (el) |
| NZ (1) | NZ555064A (el) |
| PA (1) | PA8652701A1 (el) |
| PE (1) | PE20061052A1 (el) |
| PL (1) | PL1844039T3 (el) |
| PT (1) | PT1844039E (el) |
| RS (2) | RS20070205A (el) |
| SI (1) | SI1844039T1 (el) |
| TW (1) | TWI311559B (el) |
| UY (1) | UY29213A1 (el) |
| WO (1) | WO2006050998A1 (el) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7297700B2 (en) | 2005-03-24 | 2007-11-20 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| TWI464148B (zh) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途 |
| RU2431502C2 (ru) * | 2006-07-07 | 2011-10-20 | Бош Энд Ломб Инкорпорейтед | Фармацевтические композиции для лечения сухости глаз |
| DK2049112T3 (da) | 2006-08-07 | 2012-04-23 | Bausch & Lomb | Behandling af infektioner og følgesygdomme deraf med kombinerede, dissocierede glucocorticoid-receptor-agonister og anti-infektionsmidler |
| PT2051710E (pt) * | 2006-08-07 | 2012-02-08 | Bausch & Lomb | Composições e métodos para tratar, reduzir, melhorar ou aliviar doenças oftálmicas do segmento posterior |
| EP2056799B1 (en) * | 2006-08-31 | 2013-07-31 | Bausch & Lomb Incorporated | Compositions and methods for treating or preventing glaucoma or progression thereof |
| US20110105559A1 (en) * | 2006-09-11 | 2011-05-05 | Rohrs Brian R | Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| JP2010502723A (ja) * | 2006-09-11 | 2010-01-28 | ボーシュ アンド ローム インコーポレイティド | アレルギーを治療、または制御、または軽減、または改善、または予防するための組成物と方法 |
| US20110104159A1 (en) * | 2006-09-11 | 2011-05-05 | Rohrs Brian R | Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| CA2666685A1 (en) * | 2006-11-09 | 2008-05-22 | Bausch & Lomb, Incorporated | Synthesis of selected stereoisomers of certain substituted alcohols |
| EP1982976A1 (en) * | 2007-04-18 | 2008-10-22 | Intendis GmbH | Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof |
| JP5725539B2 (ja) * | 2007-04-18 | 2015-05-27 | インテンディス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 非ステロイド抗炎症剤及びその中間体の製造方法 |
| EP2016935A1 (en) * | 2007-07-09 | 2009-01-21 | Intendis GmbH | Pharmaceutical composition for topical application of poorly soluble compounds |
| US20090042936A1 (en) * | 2007-08-10 | 2009-02-12 | Ward Keith W | Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation |
| US20090087443A1 (en) * | 2007-09-27 | 2009-04-02 | Bartels Stephen P | Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery |
| WO2009058585A2 (en) * | 2007-11-01 | 2009-05-07 | Bausch & Lomb Incorporated | Non-aqueous water-miscible materials as vehicles for drug delivery |
| US20110077270A1 (en) * | 2009-04-21 | 2011-03-31 | Pfeffer Bruce A | Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| CN101983961B (zh) * | 2010-11-24 | 2012-05-09 | 浙江启明生化科技有限公司 | 5-氨基-2-甲基喹啉的制备方法 |
| US20120316199A1 (en) | 2011-06-07 | 2012-12-13 | Ward Keith W | Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain |
| WO2017137375A1 (en) | 2016-02-12 | 2017-08-17 | Bayer Animal Health Gmbh | Mapracorat for use in the treatment of canine dermatitis |
| CN106800493B (zh) * | 2017-01-16 | 2020-06-30 | 宜昌尚诺德生物医药科技有限公司 | 一种芳硝基还原为芳胺的方法 |
| WO2020152193A1 (en) | 2019-01-22 | 2020-07-30 | Akribes Biomedical Gmbh | Selective glucocorticoid receptor modifiers for treating impaired skin wound healing |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4041482A1 (de) * | 1990-12-22 | 1992-06-25 | Boehringer Ingelheim Kg | Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine |
| NO940245D0 (no) * | 1993-01-28 | 1994-01-24 | Takeda Chemical Industries Ltd | Quinolin eller quinazolinderivater, deres fremstilling og anvendelse |
| RU2127271C1 (ru) * | 1997-03-13 | 1999-03-10 | Пермская государственная фармацевтическая академия | 5-нитрофурфурилиденгидразид 2-хлор-5,6,7,8,-тетрагидрохинолин-4-карбоновой кислоты, обладающий антимикробной активностью |
| UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| DE10215316C1 (de) * | 2002-04-02 | 2003-12-18 | Schering Ag | Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer |
| AU2003297471A1 (en) * | 2003-01-03 | 2004-08-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| US20040224992A1 (en) * | 2003-02-27 | 2004-11-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| US7179919B2 (en) * | 2004-03-18 | 2007-02-20 | Boehringer Ingelheim Pharmaceuticals, Inc. | Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
-
2004
- 2004-11-12 DE DE102004055633A patent/DE102004055633A1/de not_active Ceased
-
2005
- 2005-11-11 CA CA2586689A patent/CA2586689C/en not_active Expired - Fee Related
- 2005-11-11 PL PL05808294T patent/PL1844039T3/pl unknown
- 2005-11-11 GT GT200500330A patent/GT200500330A/es unknown
- 2005-11-11 KR KR1020077010785A patent/KR101168462B1/ko not_active IP Right Cessation
- 2005-11-11 ME MEP-136/08A patent/MEP13608A/xx unknown
- 2005-11-11 PT PT05808294T patent/PT1844039E/pt unknown
- 2005-11-11 DE DE502005007725T patent/DE502005007725D1/de active Active
- 2005-11-11 JP JP2007540615A patent/JP4460608B2/ja not_active Expired - Fee Related
- 2005-11-11 TW TW094139706A patent/TWI311559B/zh not_active IP Right Cessation
- 2005-11-11 BR BRPI0517797-9A patent/BRPI0517797A/pt not_active IP Right Cessation
- 2005-11-11 MY MYPI20055308A patent/MY141780A/en unknown
- 2005-11-11 AU AU2005303926A patent/AU2005303926B2/en not_active Ceased
- 2005-11-11 NZ NZ555064A patent/NZ555064A/en not_active IP Right Cessation
- 2005-11-11 CN CN2005800464522A patent/CN101124220B/zh not_active Expired - Fee Related
- 2005-11-11 ME MEP-2008-136A patent/ME00155B/me unknown
- 2005-11-11 RS RSP-2007/0205A patent/RS20070205A/sr unknown
- 2005-11-11 EA EA200700982A patent/EA013076B1/ru not_active IP Right Cessation
- 2005-11-11 MX MX2007005736A patent/MX2007005736A/es active IP Right Grant
- 2005-11-11 WO PCT/EP2005/012531 patent/WO2006050998A1/de active Application Filing
- 2005-11-11 RS RSP-2009/0367A patent/RS51161B/sr unknown
- 2005-11-11 ES ES05808294T patent/ES2329599T3/es active Active
- 2005-11-11 DK DK05808294T patent/DK1844039T3/da active
- 2005-11-11 SI SI200530792T patent/SI1844039T1/sl unknown
- 2005-11-11 EP EP05808294A patent/EP1844039B1/de active Active
- 2005-11-14 PE PE2005001324A patent/PE20061052A1/es not_active Application Discontinuation
- 2005-11-14 AR ARP050104767A patent/AR051767A1/es not_active Application Discontinuation
- 2005-11-14 PA PA20058652701A patent/PA8652701A1/es unknown
- 2005-11-14 UY UY29213A patent/UY29213A1/es not_active Application Discontinuation
-
2007
- 2007-05-02 IL IL182933A patent/IL182933A/en not_active IP Right Cessation
- 2007-06-11 NO NO20072963A patent/NO332405B1/no not_active IP Right Cessation
-
2008
- 2008-07-10 HK HK08107600.9A patent/HK1112243A1/xx not_active IP Right Cessation
-
2009
- 2009-09-25 HR HR20090509T patent/HRP20090509T1/hr unknown
- 2009-10-15 CY CY20091101074T patent/CY1110520T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110520T1 (el) | Παραγωγα 5-υποκατεστημενης κινολινης και ισοκινολινης· μεθοδος για την παραγωγη τους και η χρηση τους ως αντιφλεγμονωδη | |
| CY1105994T1 (el) | Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| CY1109568T1 (el) | Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων | |
| UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| NO20082266L (no) | Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser | |
| CY1106598T1 (el) | Παραγωγα κινολινης και ισοκινολινης, μεθοδος για την παραγωγη αυτων και χρηση αυτων ως αντιφλεγμονωδη μεσα | |
| ME01992B (me) | Jedinjenje diarilhidantoina | |
| NO20073790L (no) | Kjemiske forbindelser | |
| NO20073788L (no) | Kjemiske forbindelser | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| CY1109656T1 (el) | Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης | |
| EA201070786A1 (ru) | Бензофуропиримидиноны | |
| EA201000883A1 (ru) | Производные индолинона и способ их получения | |
| EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| CY1113320T1 (el) | Σπειρο-κυκλικα νιτριλια ως αναστολεις πρωτεασης | |
| ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| CY1111954T1 (el) | Παραγωγα τετραϋδροναφθαλινιου, μεθοδοι για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδη | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| RS52108B (en) | 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS | |
| ATE521609T1 (de) | Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs |